Can HPV Vaccination Combat Genital Warts?
Women's Health Summary and Comment
Yes — and the benefit extends beyond vaccinated women to their male sexual partners.
By Anna Wald, MD, MPH
November 5, 2009
Covering:
Fairley CK et al., Sex Transm Infect 2009 Oct 16
Therapeutic HPV Vaccination for Preventing Progression of Vulvar Intraepithelial Neoplasia
Women's Health Summary and Comment
Free
Clinical responses were achieved in women with grade 3 VIN who were vaccinated against HPV-16 viral oncoproteins.
By Anna Wald, MD, MPH
November 4, 2009
Covering:
Kenter GG et al., N Engl J Med 2009 Nov 5; 361:1838
Finn OJ and Edwards RP., N Engl J Med 2009 Nov 5; 361:1899
Oral Contraceptive Failure Rates
Women's Health Summary and Comment
The OC failure rate in a large European cohort was 0.75% in the first year of use.
Estrogen-Progestin Therapy and Lung Cancer in Menopausal Women
Women's Health Summary and Comment
Trying to make sense of a puzzle
By Andrew M. Kaunitz, MD
October 15, 2009
Covering:
Chlebowski RT et al., Lancet 2009 Oct 10; 374:1243
Ganti AK., Lancet 2009 Oct 10; 374:1217
Ethnicity Affects Attitudes About HPV Vaccination
Women's Health Summary and Comment
Ethnic minority women in the U.K. were less likely than white women to know about HPV and to view vaccination as acceptable.
STI and HIV Services Fall Short for Sexually Active Young Women
General Medicine Summary and Comment
More than one third of young women who receive contraceptive services are not concurrently offered STI or HIV services.
By Robert W. Rebar, MD
October 13, 2009
Covering:
Farr SL et al., Am J Obstet Gynecol 2009 Aug; 201:142.e1
Management of Chronic Pain
Comprehensive treatment for chronic pain must address both physical and psychological aspects.
By Lynn Rader, MD
October 8, 2009
Newly Approved Use for the LNG-IUS
Women's Health News in Context
FDA approves the LNG-IUS for treating patients with menorrhagia.
By Diane E. Judge, APN/CNP
October 8, 2009
Covering:
Kaunitz AM et al., Contraception 2009 Aug; 80:212
New Options for HPV Vaccine
An FDA panel recommends approval of a new indication for the quadrivalent HPV vaccine and approval of a new HPV vaccine.
By Peggy Sue Weintrub, MD
October 7, 2009
Covering:
Dooren JC., Wall Street Journal. 2009 Sep 4,
Singer N., New York Times. 2009 Sep 9,
Young S., CNNhealth.com. 2009 Sep 9,
Richwine L., Reuters website. 2009 Sep 9,
How Does Efficacy of the Contraceptive Patch Compare with That of OCs?
Women's Health Summary and Comment
Rates of unintended pregnancy were <1% for both methods.
Is Laparoscopic Uterosacral Nerve Ablation Effective for Chronic Pelvic Pain?
Women's Health Summary and Comment
British randomized trial results indicate the answer is no.
"Timing Hypothesis" for Hormone Therapy: Still Viable, or Time to Let Go?
In a new analysis, researchers examine outcomes associated with HT use in the early postmenopausal period.
LNG-IUDs for Excessive Menstrual Bleeding in Women Receiving Anticoagulant Therapy
Women's Health Summary and Comment
Heavy menstrual bleeding diminished after LNG-IUD insertion.
By Robert W. Rebar, MD
September 17, 2009
Covering:
Kilic S et al., Contraception 2009 Aug; 80:152
With OCs, Hormone Type and Amount Matter for Thrombotic Risk
Women's Health Summary and Comment
Excess risk for venous thrombosis was lowest for OCs containing levonorgestrel as well as for those with the least amount of estrogen.
By Wendy S. Biggs, MD
September 17, 2009
Covering:
Lidegaard BMJ 2009 Aug 13; 339:b2890
van Hylckama Vlieg A et al., BMJ 2009 Aug 13; 339:b2921
At What Age Do American Teens Become Sexually Active?
Women's Health Summary and Comment
Free
Age at sexual debut varies by sex, race, and ethnicity.
By Ann J. Davis, MD
September 10, 2009
Covering:
Cavazos-Rehg PA et al., Contraception 2009 Aug; 80:158
For Cervical Cancer, Age Matters — Both the Woman's and Her HPV Infection's
Women's Health Summary and Comment
Persistent HPV infection with carcinogenic HPV genotypes was associated with higher risk for CIN 2+; cytology screening was most beneficial in women 35 or older.
By Wendy S. Biggs, MD
September 10, 2009
Covering:
Castle PE et al., BMJ 2009 Jul 28; 339:b2569
Sasieni P et al., BMJ 2009 Jul 28; 339:b2968
Ronco G et al., BMJ 2009 Jul 28; 339:b3005
Quadrivalent HPV Vaccine: Postlicensure Safety Data and Marketing Controversies
Women's Health Summary and Comment
Free
Causal nature of qHPV vaccination in relation to adverse events remains unclear; marketing has been criticized for focusing on cervical cancer prevention.
By Ann J. Davis, MD
September 3, 2009
Covering:
Slade BA et al., JAMA 2009 Aug 19; 302:750
Rothman SM and Rothman DJ., JAMA 2009 Aug 19; 302:781
Haug C., JAMA 2009 Aug 19; 302:795
DMPA and Weight Gain
Women's Health Summary and Comment
Initial excessive weight gain with DMPA use predicted continued excessive gain.
By Ann J. Davis, MD
September 3, 2009
Covering:
Le Y-CL et al., Obstet Gynecol 2009 Aug; 114:279
Vaginal Estrogen Relieves Postmenopausal Vaginal Symptoms
Women's Health Summary and Comment
Three different regimens of vaginal estrogen were better than placebo at relieving women's most bothersome symptoms, primarily vaginal dryness and dyspareunia.
By Diane E. Judge, APN/CNP
September 3, 2009
Covering:
Bachmann G et al., Menopause 2009 Jul/Aug; 16:719
Freedman M et al., Menopause 2009 Jul/Aug; 16:735
Ovarian Status and Risk for Lung Cancer
Women's Health Summary and Comment
Further evidence that functional ovaries protect against lung cancer
Salivary Testosterone Levels Do Not Reflect Serum Levels in Postmenopausal Women
Women's Health Summary and Comment
Poor correlation does not support routine measurement of salivary testosterone.
By Robert W. Rebar, MD
August 13, 2009
Covering:
Flyckt RL et al., Menopause 2009 Jul/Aug; 16:680
The Other Shoe Drops: New WHI Analysis
Women's Health Summary and Comment
Free
Unfavorable balance of risks and benefits also applies to women who initiated HT within 5 years after menopause.
By Diane E. Judge, APN/CNP
August 6, 2009
Covering:
Prentice RL et al., Am J Epidemiol 2009 Jul 1; 170:12
Banks E and Canfell K., Am J Epidemiol 2009 Jul 1; 170:24
Does Hormonal Contraception Accelerate HIV Progression?
Women's Health Summary and Comment
Use of either DMPA or OCPs was associated with hastened unfavorable disease outcomes.
By Anna Wald, MD, MPH
July 30, 2009
Covering:
Stringer EM et al., AIDS 2009 Jul 17; 23:1377
STIs in Children When Sexual Abuse Is Suspected
Comprehensive testing is important in such children. Nucleic acid amplification tests on urine specimens were more sensitive than culture for detecting <$EMPH_O>C. trachomatis<$EMPH_C> and <$EMPH_O>N. gonorrhoeae.<$EMPH_C>
By Howard Bauchner, MD
July 29, 2009
Covering:
Girardet RG et al., Pediatrics 2009 Jul; 124:79
Black CM et al., Pediatr Infect Dis J 2009 Jul; 28:608
New Emergency Contraception Developments
Women's Health News in Context
Free
One-dose formulation is approved; two-dose formulation goes generic.
By Diane E. Judge, APN/CNP
July 23, 2009
Covering:
North Wales, PA: Teva Pharmaceuticals, Inc. 2009 Jul 10Budapest, Hungary: Gedeon Richter, Ltd., for Duramed Pharmaceuticals, Inc. 2009 Silver Spring, MD: Food and Drug Administration 2009 Jun 24
